Mesoblast Newsroom

Mesoblast Analyst Ratings

BenzingaJun 20 13:42 ET

Mesoblast Analyst Ratings

BenzingaJun 4 13:22 ET

Analysts Offer Insights on Healthcare Companies: Aprea Therapeutics (APRE), Biogen (BIIB) and Mesoblast Limited (OtherMEOBF)

TipRanksMar 27 08:25 ET

Mesoblast (MESO) Gets a Hold From Piper Sandler

TipRanksMar 12 06:36 ET

Mesoblast Limited (MEOBF) Receives a Buy From Jefferies

TipRanksMar 3 07:16 ET

Mesoblast (MESO) Gets a Hold From Piper Sandler

TipRanksFeb 29 07:48 ET

Jefferies Keeps Their Buy Rating on Mesoblast Limited (MEOBF)

TipRanksDec 26, 2023 07:38 ET

Analysts Are Bullish on These Healthcare Stocks: Guangzhou Baiyunshan Pharmaceutical Holdings Company (GZPHF), Mesoblast Limited (MEOBF)

TipRanksDec 24, 2023 07:51 ET

Analysts Offer Insights on Healthcare Companies: Haemonetics (HAE), Mesoblast (MESO) and HealthStream (HSTM)

TipRanksSep 21, 2023 10:51 ET

Cantor Fitzgerald Reiterates Overweight on Mesoblast, Maintains $17 Price Target

BenzingaSep 21, 2023 08:58 ET

Mesoblast Analyst Ratings

BenzingaSep 21, 2023 08:56 ET

Analyst Bullish On Cell Therapy Player Mesoblast, But Cuts Price Target

BenzingaAug 31, 2023 13:49 ET

William Blair Reaffirms Their Hold Rating on Mesoblast (MESO)

TipRanksAug 31, 2023 10:45 ET

Cantor Fitzgerald Maintains Overweight on Mesoblast, Lowers Price Target to $17

BenzingaAug 31, 2023 09:19 ET

Mesoblast Analyst Ratings

BenzingaAug 31, 2023 09:18 ET

Analysts Offer Insights on Healthcare Companies: Cooper Co (COO) and Mesoblast (MESO)

TipRanksAug 31, 2023 08:00 ET

Mesoblast Analyst Ratings

BenzingaAug 7, 2023 09:20 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Stryker (SYK), Mesoblast (MESO) and Ultragenyx Pharmaceutical (RARE)

TipRanksAug 4, 2023 11:12 ET

Piper Sandler Downgrades Mesoblast to Neutral, Lowers Price Target to $2

BenzingaAug 4, 2023 07:29 ET

Chardan Capital Maintains Sell on Mesoblast, Lowers Price Target to $1.5

BenzingaAug 4, 2023 06:37 ET